Larimar Therapeutics GAAP EPS of -$0.73 misses by $0.22 [Seeking Alpha]
Larimar Therapeutics, Inc. (LRMR)
Company Research
Source: Seeking Alpha
$244.5 million in pro forma cash, cash equivalents and marketable securities as of December 31, 2025, with projected cash runway into the second quarter of 2027 Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up More on Larimar Therapeutics Larimar Therapeutics: The Market Is Mispricing A Potential Standard Of Care Larimar Therapeutics, Inc. (LRMR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Larimar Therapeutics, Inc. (LRMR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Larimar Therapeutics stock dips after pricing $100M share offering Larimar Therapeutics launches proposed $75 million public offering Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
LRMR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LRMR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LRMR alerts
High impacting Larimar Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LRMR
News
- Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $12.00 to $13.00. They now have an "outperform" rating on the stock.MarketBeat
- Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- Larimar Therapeutics to Participate in Upcoming Investor Conferences in MarchGlobeNewswire
- Larimar Therapeutics price target raised to $12 from $11 at Wedbush [Yahoo! Finance]Yahoo! Finance
- Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $11.00 to $12.00. They now have an "outperform" rating on the stock.MarketBeat
LRMR
Earnings
- 3/19/26 - Miss
LRMR
Sec Filings
- 3/19/26 - Form S-8
- 3/19/26 - Form 10-K
- 3/19/26 - Form 8-K
- LRMR's page on the SEC website